📢 For investors and media: We’ve just published our Interim Report for the second quarter of 2025. Financial analysts and media are invited to our webcast and presentation of the results today at 2 pm (CET). Read the full press release (17 July 2025) and get the details here: https://lnkd.in/dXw5btUy
Camurus
Tillverkning av läkemedel
Lund, Skåne 10 163 följare
Committed to developing and commercializing long-acting treatments for patients with severe and chronic diseases.
Om oss
Camurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases. We empower patients, support caregivers and create value for society by developing and giving access to innovative, long-acting medicines. To fulfill our commitment, we are determined to conduct our business in a sustainable manner. New drug products with best-in-class potential are conceived based on the company's proprietary FluidCrystal® technology and extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of treatment of opioid dependence, cancer, and endocrine disorders, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX.
- Webbplats
-
http://www.camurus.com
Extern länk för Camurus
- Bransch
- Tillverkning av läkemedel
- Företagsstorlek
- 201–500 anställda
- Huvudkontor
- Lund, Skåne
- Typ
- Publikt aktiebolag
- Grundat
- 1991
- Specialistområden
- Drug formulation technologies, Development and commercialization of innovative specialty medicines, Pharmaceutical research, Drug delivery systems, Opioid dependence treatment, Lipid phase nanostructures och Rare diseases
Adresser
-
Primär
Ideon Science Park
Lund, Skåne 223 70, SE
Anställda på Camurus
Uppdateringar
-
Hormonal disorders caused by endocrine diseases can lead to a wide range of symptoms, many of which deeply affect daily life and well-being. One such disorder is acromegaly, which often requires lifelong medication. Between 12–15 July, we are presenting Camurus’ research in the field of acromegaly at ENDO 2025 in San Francisco. Camurus is actively participating in leading scientific meetings. To access medical materials presented at these congresses, healthcare professionals are invited to visit Camurus’ Medical Hub: https://lnkd.in/dXc-WxYv #EndocrineDisorders #HormonalHealth #Acromegaly #MedicalResearch #ENDO2025 #Camurus
-
-
We are hiring a Senior Project Manager R&D to join us at our headquarters in Lund, Sweden! In this role, you will ensure effective project management leadership of Camurus’ projects across a broad range of development stages. You will oversee the end-to-end planning, execution, and delivery of pharmaceutical R&D projects, ensuring alignment with company goals and regulatory standards. This is a great opportunity to take on a key role in Camurus, contributing to the success of pharmaceutical R&D projects, driving innovation, and delivering impactful solutions for unmet medical needs. Learn more and apply here: https://lnkd.in/d6KB6Gzu #Camurus #Hiring #Openposition
-
-
We are making progress! We are pleased to announce a major advancement of our research and development pipeline. Investors are invited to read more at: https://lnkd.in/duEviATV
-
-
We are hiring a Supply Chain Manager! Join our Distribution & Supply Chain team at Camurus’ headquarters in Lund, Sweden – and be part of a science-led biopharmaceutical company making a real difference in patients’ lives. In this role, you will take ownership of the commercial supply chain to selected markets – collaborating closely with teams across Manufacturing, Quality, Regulatory, Commercial and Finance. You will be part of a virtual supply chain setup, working with external manufacturing partners and logistics providers. This is a broad and hands-on role, offering a mix of planning, coordination, improvement work, and operational execution. 📩 Learn more and apply here: https://lnkd.in/dXUPbiMJ
-
-
Today, on the UN World Drug Day, we want to focus on the importance of an open dialogue about mental health and emotional distress. We are proud to sponsor Dianova International and their campaign Voices without Stigma, supporting young people's mental health to avoid substance use as a coping mechanism. The campaign highlights the importance of making space for young people to express what truly matters to them, and to remove the stigma surrounding addiction and mental health. Learn more about the campaign here: https://lnkd.in/d4ZVkK3w #VoicesWithoutStigma #worlddrugday
-
Happy Midsummer! Tomorrow, Sweden celebrates Midsummer, a cherished holiday that honors the summer season with food, flowers, and joyful gatherings. For over a thousand years, this tradition has marked the return of light and hope – so essential after the long, dark northern winter. This year, coming together for hope feels ever so important!
-
-
We are excited to be on site at the BIO International Convention 2025 in Boston. Our Business Development team – Fredrik Joabsson, Chief Business Development Officer, and Linn Antberg, Director Business Development & Alliance Management – is attending the convention from 16 to 19 June. As the world’s largest and most comprehensive biotech event, BIO 2025 is a great platform for forging partnerships and discovering the latest developments in the field. Our team is engaging in conversations, exploring new collaboration opportunities, and gaining insights into innovative approaches to improve the lives of patients with chronic and severe diseases. 🔗 Learn more about Camurus and our partnering approach: https://lnkd.in/e9THfKdD #BIO2025 #Camurus #Biotech #Pharma #Innovation #Partnering
-
-
We are proud to sponsor the LINXS at Science Village Inaugural Conference, starting today at the Loop in Lund, Sweden. LINXS is not only our closest neighbor – with offices just a floor below ours – but also a vital institute that brings together researchers from around the world to leverage the cutting-edge synchrotron and neutron beam facilities at MAX IV and the European Spallation Source. With life science and soft matter among LINXS’s focus areas, we at Camurus are excited to follow the outcomes of their activities. The LINXS at Science Village Inaugural Conference takes place on 17–18 June. 👉 Find out more here: https://lnkd.in/dSss2tsS
-
-
🎉 Our CEO, Fredrik Tiberg, was just named Chief Executive of the Year at the European Mediscience Awards 2025! Hurray!!!!🏆 This is a prestigious recognition of Fredrik’s visionary leadership, scientific excellence, and unwavering commitment to creating long-term value for patients and shareholders alike. Our Chief Commercial Officer, Richard Jameson, proudly accepted the award on Fredrik’s behalf at the ceremony in London last night. A huge congratulations to Fredrik and team for this recognition of Camurus’ significant progress! 👏
-
Liknande sidor
Finansiering
Senaste finansieringsrunda
Okänd serie57 430 129,00 US$